功能性胃肠疾病:历史、病理生理学、临床特征与罗马IV标准
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV.
作者信息
Drossman Douglas A
出版信息
Gastroenterology. 2016 Feb 19. doi: 10.1053/j.gastro.2016.02.032.
Functional gastrointestinal disorders (FGIDs), the most common diagnoses in gastroenterology are recognized by morphological and physiological abnormalities that often occur in combination including motility disturbance, visceral hypersensitivity, altered mucosal and immune function, altered gut microbiota and altered central nervous system processing. Research on these gut-brain interaction disorders is based on using specific diagnostic criteria. The Rome Foundation has played a pivotal role in creating diagnostic criteria thus operationalizing the dissemination of new knowledge in the field of FGIDs. Rome IV is a compendium of the knowledge accumulated since Rome III was published 10 years ago. It improves upon Rome III by: 1) updating the basic and clinical literature, 2) offering new information on gut microenvironment, gut-brain interactions, pharmacogenomics, biopsychosocial, gender and cross cultural understandings of FGIDs, 3) reduces the use of imprecise and occassionally stigmatizing terms when possible, 4) uses updated diagnostic algorithms, 5) incorporates information on the patient illness experience, and physiological subgroups or biomarkers that might lead to more targeted treatment. This introductory article sets the stage for the remaining 17 articles that follow and offers an historical overview of the FGIDs field, differentiates FGIDs from motility and structural disorders, discusses the changes from Rome III, reviews the Rome committee process, provides a biopsychosocial pathophysiological conceptualization of FGIDs, and offers an approach to patient care.
功能性胃肠疾病(FGIDs)是胃肠病学中最常见的诊断类型,其特征是形态学和生理学异常,这些异常通常同时出现,包括动力障碍、内脏超敏反应、黏膜和免疫功能改变、肠道微生物群改变以及中枢神经系统处理过程改变。对这些肠-脑相互作用障碍的研究基于特定的诊断标准。罗马基金会在制定诊断标准方面发挥了关键作用,从而推动了FGIDs领域新知识的传播。《罗马IV》是自10年前《罗马III》出版以来积累的知识汇编。它在以下方面对《罗马III》进行了改进:1)更新基础和临床文献;2)提供关于肠道微环境、肠-脑相互作用、药物基因组学、生物心理社会学、性别以及FGIDs跨文化理解的新信息;3)尽可能减少使用不精确且有时带有污名化的术语;4)采用更新的诊断算法;5)纳入有关患者疾病体验以及可能导致更有针对性治疗的生理亚组或生物标志物的信息。这篇介绍性文章为后续的17篇文章奠定了基础,并提供了FGIDs领域的历史概述,区分了FGIDs与动力和结构性疾病,讨论了与《罗马III》的变化,回顾了罗马委员会的流程,提供了FGIDs的生物心理社会病理生理学概念化,并提出了患者护理方法。